SUBSCRIBE
SUBSCRIBE

CRISPR Therapeutics

NEWS
Arthrex to Create 1,000 Jobs With New $74M Facilit
Biotech Bay
Meet the 4 Biotechs That are Disrupting Healthcare
It’s not always easy to see when a company is a “disruptor,” which is to say, that it causes a paradigm shift in how an industry operates.
November 14, 2017
 · 
3 min read
 · 
Mark Terry
Founding CRISPR CEO to Step Down for Personal Reasons, New Leader Named
Business
Founding CRISPR CEO to Step Down for Personal Reasons, New Leader Named
October 2, 2017
 · 
2 min read
Business
CRISPR To Lose Its CFO In September, Hunt For Successor Begins
July 27, 2017
 · 
1 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing
May 31, 2017
 · 
3 min read
Deals
CRISPR’s Surprisingly Low IPO… Why Are Investors Discouraged?
October 21, 2016
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
CRISPR IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year
October 19, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Gene Editing Phenom CRISPR Files for $90 Million IPO
September 12, 2016
 · 
3 min read
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain
Business
Bayer and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area
August 19, 2016
 · 
3 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Press Releases
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
March 16, 2026
 · 
9 min read
Press Releases
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
March 11, 2026
 · 
7 min read
Press Releases
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
March 10, 2026
 · 
4 min read
Press Releases
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
 · 
17 min read
Press Releases
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
January 13, 2026
 · 
15 min read
Press Releases
CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
 · 
2 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
 · 
9 min read
Press Releases
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
November 24, 2025
 · 
18 min read
Press Releases
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
November 18, 2025
 · 
3 min read
Press Releases
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
November 11, 2025
 · 
21 min read
Load More